Literature DB >> 8806504

Differential antigen recognition by T cells from the spleen and central nervous system of coronavirus-infected mice.

R F Castro1, S Perlman.   

Abstract

CD8+ cytotoxic T lymphocytes (CTLs) isolated from the central nervous system (CNS) of C57BI/6 mice acutely infected with mouse hepatitis virus, strain JHM (MHV-JHM), and analyzed in a direct ex vivo cytotoxicity assay recognize two epitopes (H-2Db- and H-2Kb-restricted encompassing amino acids 510-518 and 598-605, respectively) within the surface (S) glycoprotein. In contrast, CD8+ T cells isolated from the spleens of mice inoculated intraperitoneally with MHV-JHM and restimulated in vitro only respond to the H-2Db-restricted epitope. In this report, the preferential recognition of the H-2Db-restricted epitope is confirmed using splenocytes stimulated in vitro with either MHV-JHM-infected MC57 cells or with a cell line expressing the S protein and analyzed in secondary CTL assays. To determine whether these results represent a difference in epitope recognition between the spleen and CNS, secondary CTL assays were performed using spleen cells coated with peptides encompassing the CTL epitopes as stimulators. Under these conditions, both epitopes sensitized cells for lysis by spleen-derived CTLs, suggesting that both epitopes were recognized by splenic CD8+ T cells after infection in vivo. Furthermore, limiting dilution analysis indicated that the precursor frequency of splenic CD8+ T cells specific for both the H-2Kb- and H-2Db-restricted epitopes were not significantly different. Thus, the results suggest that in vitro stimulation of splenocytes specific for the H-2Kb-restricted epitope is inefficient after endogenous processing but that this inefficiency can be corrected if peptide is provided exogenously at sufficiently high concentrations. As a consequence, the results also show that cells responsive to both of the previously identified CNS-derived CD8+ T cell epitopes are present in the infected spleen at nearly the same frequency.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8806504      PMCID: PMC7131764          DOI: 10.1006/viro.1996.0415

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Kinetics of virus-specific CD8+ -T-cell expansion and trafficking following central nervous system infection.

Authors:  Norman W Marten; Stephen A Stohlman; Jiehao Zhou; Cornelia C Bergmann
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

2.  Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis.

Authors:  N Seo; Y Tokura; T Nishijima; H Hashizume; F Furukawa; M Takigawa
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

3.  Effects of an epitope-specific CD8+ T-cell response on murine coronavirus central nervous system disease: protection from virus replication and antigen spread and selection of epitope escape mutants.

Authors:  Ming Ming Chua; Katherine C MacNamara; Lani San Mateo; Hao Shen; Susan R Weiss
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

4.  Infection with cytotoxic T-lymphocyte escape mutants results in increased mortality and growth retardation in mice infected with a neurotropic coronavirus.

Authors:  L Pewe; S Xue; S Perlman
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

5.  Immune responses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine.

Authors:  Ping Zhao; Jie Cao; Lan-Juan Zhao; Zhao-Lin Qin; Jin-Shan Ke; Wei Pan; Hao Ren; Jian-Guo Yu; Zhong-Tian Qi
Journal:  Virology       Date:  2005-01-05       Impact factor: 3.616

6.  Differential regulation of innate and adaptive immune responses in viral encephalitis.

Authors:  Julia D Rempel; Shannon J Murray; Jeffrey Meisner; Michael J Buchmeier
Journal:  Virology       Date:  2004-01-05       Impact factor: 3.616

Review 7.  Selection of and evasion from cytotoxic T cell responses in the central nervous system.

Authors:  S Perlman; G F Wu
Journal:  Adv Virus Res       Date:  2001       Impact factor: 9.937

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.